Loading...
Loading...
Sunesis
Pharmaceuticals, Inc.
SNSS today announced the closing of two
previously disclosed financings. Royalty Pharma has invested $25.0 million
under its royalty arrangement with Sunesis, and, in a separate transaction, a
syndicate of lenders have funded the second tranche of $15.0 million under
their $25.0 million loan facility with the company.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in